Darou Andisheh Novin Shargh

Darou Andisheh Novin Shargh (DANS Pharma) is an Iranian pharmaceutical company headquartered in Mashhad, specializing in the research, development, and production of innovative medicinal products and dietary supplements. The company is notably recognized for its Crocina product line, which utilizes crocin—a bioactive compound derived from saffron—for the treatment of various conditions including depression and neurodegenerative diseases. DANS Pharma operates as a knowledge-based entity, bridging the gap between academic research and industrial manufacturing. Its facilities are designed to meet international Good Manufacturing Practice (GMP) standards, supporting a portfolio that includes both herbal-based treatments and conventional generic pharmaceuticals. The company maintains strong ties with academic institutions to drive its R&D efforts in natural product pharmacology.